Checkpoint Inhibitor Pneumonitis: Too Clinically Serious For Benefit?

Research output: Contribution to journalEditorial

2 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)332-335
Number of pages4
JournalJournal of Thoracic Oncology
Volume14
Issue number3
DOIs
StatePublished - Mar 1 2019

Fingerprint

Pneumonia

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine

Cite this

Checkpoint Inhibitor Pneumonitis : Too Clinically Serious For Benefit? / Le, Tri; Minna, John D; Gerber, David E.

In: Journal of Thoracic Oncology, Vol. 14, No. 3, 01.03.2019, p. 332-335.

Research output: Contribution to journalEditorial

@article{d0c19bed3f8243da94fccd5c3c9b753f,
title = "Checkpoint Inhibitor Pneumonitis: Too Clinically Serious For Benefit?",
author = "Tri Le and Minna, {John D} and Gerber, {David E}",
year = "2019",
month = "3",
day = "1",
doi = "10.1016/j.jtho.2018.12.017",
language = "English (US)",
volume = "14",
pages = "332--335",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "International Association for the Study of Lung Cancer",
number = "3",

}

TY - JOUR

T1 - Checkpoint Inhibitor Pneumonitis

T2 - Too Clinically Serious For Benefit?

AU - Le, Tri

AU - Minna, John D

AU - Gerber, David E

PY - 2019/3/1

Y1 - 2019/3/1

UR - http://www.scopus.com/inward/record.url?scp=85061648976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061648976&partnerID=8YFLogxK

U2 - 10.1016/j.jtho.2018.12.017

DO - 10.1016/j.jtho.2018.12.017

M3 - Editorial

C2 - 30782379

AN - SCOPUS:85061648976

VL - 14

SP - 332

EP - 335

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

SN - 1556-0864

IS - 3

ER -